Alan Gill

1.8k total citations
34 papers, 1.1k citations indexed

About

Alan Gill is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, Alan Gill has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 7 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Alan Gill's work include Amyotrophic Lateral Sclerosis Research (10 papers), Neurogenetic and Muscular Disorders Research (6 papers) and Neonatal Respiratory Health Research (4 papers). Alan Gill is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (10 papers), Neurogenetic and Muscular Disorders Research (6 papers) and Neonatal Respiratory Health Research (4 papers). Alan Gill collaborates with scholars based in United States, United Kingdom and Switzerland. Alan Gill's co-authors include A M Weindling, Fernando G. Vieira, Joshua D. Kidd, Kenneth Thompson, Steven Perrin, Theo Hatzipetros, Beth Levine, Monica Z. Wang, Ko‐Chung Lin and R. Blake Pepinsky and has published in prestigious journals such as Nature Genetics, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Alan Gill

33 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan Gill United States	18	355	309	147	138	131	34	1.1k
Shiguang Zhao China	22	306 0.9×	386 1.2×	168 1.1×	166 1.2×	102 0.8×	46	1.1k
Shobu Shibata Japan	25	435 1.2×	409 1.3×	217 1.5×	323 2.3×	85 0.6×	65	1.4k
Gillian M. Borthwick United Kingdom	19	287 0.8×	1.1k 3.4×	158 1.1×	81 0.6×	237 1.8×	28	1.8k
Yuzo Matsumoto Japan	23	439 1.2×	256 0.8×	114 0.8×	61 0.4×	88 0.7×	73	1.3k
Steven D. Rhodes United States	17	288 0.8×	521 1.7×	96 0.7×	144 1.0×	111 0.8×	53	1.3k
Zhiyuan Zhu China	19	171 0.5×	554 1.8×	119 0.8×	81 0.6×	161 1.2×	46	1.2k
Liliana Viera United States	17	342 1.0×	647 2.1×	190 1.3×	291 2.1×	311 2.4×	34	1.5k
Kar‐Ming Fung United States	18	390 1.1×	915 3.0×	330 2.2×	128 0.9×	55 0.4×	39	1.6k
Kazunori Yamanaka Japan	17	125 0.4×	469 1.5×	56 0.4×	91 0.7×	113 0.9×	45	1.0k
Zhaohui He China	17	264 0.7×	388 1.3×	48 0.3×	165 1.2×	66 0.5×	54	909

Countries citing papers authored by Alan Gill

Since Specialization

Citations

This map shows the geographic impact of Alan Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Gill more than expected).

Fields of papers citing papers by Alan Gill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Gill. The network helps show where Alan Gill may publish in the future.

Co-authorship network of co-authors of Alan Gill

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Gill. A scholar is included among the top collaborators of Alan Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Gill. Alan Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vieira, Fernando G., Joshua D. Kidd, Andrew Moreno, et al.. (2024). PERK modulation, with GSK2606414, Sephin1 or salubrinal, failed to produce therapeutic benefits in the SOD1G93A mouse model of ALS. PLoS ONE. 19(2). e0292190–e0292190. 1 indexed citations

Anwar, Imran J., Dora M. Berman, Isabel DeLaura, et al.. (2023). The anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates. Science Translational Medicine. 15(711). eadf6376–eadf6376. 26 indexed citations

Hatzipetros, Theo, Joshua D. Kidd, Beth Levine, et al.. (2019). SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS. Scientific Reports. 9(1). 6724–6724. 50 indexed citations

Vieira, Fernando G., Theo Hatzipetros, Kenneth Thompson, et al.. (2017). CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits. IBRO Reports. 2. 47–53. 32 indexed citations

Hatzipetros, Theo, et al.. (2015). A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS. Journal of Visualized Experiments. 73 indexed citations

Vieira, Fernando G., Joshua D. Kidd, Kenneth Thompson, et al.. (2015). Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS. PLoS ONE. 10(8). e0135570–e0135570. 64 indexed citations

Vieira, Fernando G., Joshua D. Kidd, Beth Levine, et al.. (2014). Dexpramipexole Is Ineffective in Two Models of ALS Related Neurodegeneration. PLoS ONE. 9(12). e91608–e91608. 23 indexed citations

Lincecum, John, Fernando G. Vieira, Monica Z. Wang, et al.. (2010). From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis. Nature Genetics. 42(5). 392–399. 96 indexed citations

Gill, Alan, et al.. (2009). Protective Effect of Tonapofylline (BG9928), an Adenosine A<sub>1</sub> Receptor Antagonist, against Cisplatin-Induced Acute Kidney Injury in Rats. American Journal of Nephrology. 30(6). 521–526. 22 indexed citations

10.

Gill, Alan, Joshua D. Kidd, Fernando G. Vieira, Kenneth Thompson, & Steven Perrin. (2009). No Benefit from Chronic Lithium Dosing in a Sibling-Matched, Gender Balanced, Investigator-Blinded Trial Using a Standard Mouse Model of Familial ALS. PLoS ONE. 4(8). e6489–e6489. 66 indexed citations

11.

Pepinsky, R. Blake, Mark Cornebise, Alan Gill, et al.. (2005). Design, Synthesis, and Analysis of a Polyethelene Glycol-Modified (PEGylated) Small Molecule Inhibitor of Integrin α4β1 with Improved Pharmaceutical Properties. Journal of Pharmacology and Experimental Therapeutics. 312(2). 742–750. 17 indexed citations

12.

Schwarz, Kathleen B., P R Dear, Alan Gill, S J Newell, & Michael Richards. (2005). EFFECTS OF TRANSFUSION IN ANEMIA OF PREMATURITY. Pediatric Hematology and Oncology. 22(7). 551–559. 6 indexed citations

13.

Gill, Alan, et al.. (2003). CBF Reactivity in Hypotensive and Normotensive Preterm Infants. Pediatric Research. 54(6). 848–853. 37 indexed citations

14.

Talwar, Dinesh, et al.. (2002). Extraction and separation of urinary catecholamines as their diphenyl boronate complexes using C18 solid-phase extraction sorbent and high-performance liquid chromatography. Journal of Chromatography B. 769(2). 341–349. 51 indexed citations

15.

Abraham, William M., Alan Gill, Ashfaq Ahmed, et al.. (2000). A Small-Molecule, Tight-binding Inhibitor of the Integrin α4β1 Blocks Antigen-induced Airway Responses and Inflammation in Experimental Asthma in Sheep. American Journal of Respiratory and Critical Care Medicine. 162(2). 603–611. 70 indexed citations

16.

Lobb, Roy R., William M. Abraham, Linda C. Burkly, et al.. (1996). Pathophysiologic Role of α4 Integrins in the Lung. Annals of the New York Academy of Sciences. 796(1). 113–123. 30 indexed citations

17.

Raffa, Robert B., Marylyn M. Addo, & Alan Gill. (1992). Supraspinal administration of [D-Met2]FMRFamide produces a naloxone-sensitive increase in heart rate in unrestrained spontaneously hypertensive rats. Neuropeptides. 21(4). 201–205. 4 indexed citations

18.

Kukla, Michael J., Henry J. Breslin, & Alan Gill. (1990). Antihypertensive dihydropyridines with 1,4,4-trisubstitution. Journal of Medicinal Chemistry. 33(1). 223–228. 6 indexed citations

19.

Flaim, Stephen F., Maria T. Stranieri, Alan Gill, John R. Carson, & Melvin D. Brannan. (1990). Effects of the Novel Coronary Selective Calcium Channel Blocker, McN-6186, on Cardiocirculatory Dynamics Coronary Vascular Resistance, and Cardiac Output Distribution in Normal, Conscious Rats. Journal of Cardiovascular Pharmacology. 15(5). 780–790. 2 indexed citations

20.

Flaim, Stephen F., Maria T. Stranieri, Alan Gill, John R. Carson, & Melvin D. Brannan. (1988). Effects of the Novel Calcium Channel Blocker, McN-5691, on Cardiocirculatory Dynamics and Cardiac Output Distribution in Conscious Spontaneously Hypertensive Rat. Journal of Cardiovascular Pharmacology. 11(4). 489–500. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact